Privia Health Group Inc (NASDAQ: PRVA) on Tuesday, soared 3.86% from the previous trading day ,before settling in for the closing price of $18.66. Within the past 52 weeks, PRVA’s price has moved between $17.54 and $30.15.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 20.87%. The company achieved an average annual earnings per share of 27.19%. With a float of $101.89 million, this company’s outstanding shares have now reached $118.22 million.
Let’s determine the extent of company efficiency that accounts for 1102 employees.
Privia Health Group Inc (PRVA) Breakdown of a Key Holders of the stock
Observing investor behavior towards Health Information Services industry stocks is more important than anything else. The insider ownership of Privia Health Group Inc is 14.06%, while institutional ownership is 95.93%. The most recent insider transaction that took place on Apr 02 ’24, was worth 69,889. In this transaction EVP & Chief Financial Officer of this company sold 3,933 shares at a rate of $17.77, taking the stock ownership to the 262,279 shares. Before that another transaction happened on Mar 11 ’24, when Company’s Director sold 400 for $23.02, making the entire transaction worth $9,208. This insider now owns 5,445,018 shares in total.
Privia Health Group Inc (PRVA) Recent Fiscal highlights
As on 12/30/2023, Multinational firm has announced its last quarter scores, in which it reported $0.02 earnings per share (EPS) for the period falling under the consensus outlook (set at $0.04) by -$0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 27.19% per share during the next fiscal year.
Privia Health Group Inc (NASDAQ: PRVA) Trading Performance Indicators
Privia Health Group Inc (PRVA) is currently performing well based on its current performance indicators. A quick ratio of 1.81 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.39. Likewise, its price to free cash flow for the trailing twelve months is 28.49.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.19, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 0.33 in one year’s time.
Technical Analysis of Privia Health Group Inc (PRVA)
Looking closely at Privia Health Group Inc (NASDAQ: PRVA), its last 5-days average volume was 0.69 million, which is a drop from its year-to-date volume of 0.97 million. As of the previous 9 days, the stock’s Stochastic %D was 47.16%. Additionally, its Average True Range was 0.88.
During the past 100 days, Privia Health Group Inc’s (PRVA) raw stochastic average was set at 27.02%, which indicates a significant decrease from 49.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.42% in the past 14 days, which was lower than the 50.73% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $20.45, while its 200-day Moving Average is $22.93. However, in the short run, Privia Health Group Inc’s stock first resistance to watch stands at $19.58. Second resistance stands at $19.78. The third major resistance level sits at $20.17. If the price goes on to break the first support level at $18.99, it is likely to go to the next support level at $18.60. Now, if the price goes above the second support level, the third support stands at $18.40.
Privia Health Group Inc (NASDAQ: PRVA) Key Stats
Market capitalization of the company is 2.30 billion based on 118,656K outstanding shares. Right now, sales total 1,658 M and income totals 23,080 K. The company made 440,830 K in profit during its latest quarter, and 2,840 K in sales during its previous quarter.
